Dual immune resistance regulators | Cytotoxicity resistance regulators | ||||
Gene | log2 FC | Adjusted p value | Gene | log2 FC | Adjusted p value |
ALDOA | −0.23850373 | 0.007872359 | BIRC5 | 0.001616317 | 0.445455851 |
ATG14 | −0.16059775 | 0.024714023 | CENPM | −0.02500863 | 0.490792818 |
BCS1L | −0.2221878 | 0.000232251 | CHMP3 | −0.04904437 | 0.288401697 |
CDC37 | −0.13924483 | 0.013138636 | CUL1 | 0.043406838 | 0.357618622 |
CINP | −0.27976923 | 0.00013675 | GPN2 | −0.02216915 | 0.436860262 |
EMC6 | −0.17631624 | 0.003022816 | GPN3 | 0.054197902 | 0.490792818 |
IARS2 | −0.19416706 | 0.024714023 | GTF2A2 | −0.1117453 | 0.129400101 |
INTS1 | −0.37983256 | 0.000232251 | IKBKB | 0.023644056 | 0.468032515 |
LAGE3 | −0.23234266 | 0.003485045 | IKBKG | −0.01643131 | 0.497356193 |
MRPL24 | −0.40095843 | 5.04E-07 | MAP3K7 | 0.103247863 | 0.161295174 |
MRPL34 | −0.16222743 | 0.032171236 | MED14 | 0.04430575 | 0.405754176 |
MRPS18A | −0.1803627 | 0.003485045 | MED20 | −0.16001865 | 0.051695527 |
MRPS25 | −0.27447257 | 0.001960487 | MED28 | 0.014100544 | 0.479837582 |
NDUFA13 | −0.24127607 | 0.00077217 | MED31 | −0.00650653 | 0.431123004 |
NDUFA8 | −0.14254375 | 0.036841903 | MED4 | 0.029429293 | 0.490792818 |
NDUFC2 | −0.22780474 | 0.009719995 | MED8 | 0.025281119 | 0.469465067 |
NDUFS2 | −0.27413473 | 0.000150695 | NEDD8 | −0.10738096 | 0.057838148 |
NDUFS8 | −0.21857521 | 0.010858763 | OSGEP | −0.09611608 | 0.210488175 |
NELFCD | −0.13824149 | 0.021162677 | PABPN1 | −0.04169503 | 0.369604337 |
NFRKB | −0.14577584 | 0.048562248 | PISD | −0.00640109 | 0.445455851 |
OXA1L | −0.24881438 | 0.000150695 | POLR2C | −0.04248415 | 0.389528608 |
PFDN2 | −0.20551461 | 0.010483911 | POLR3B | −0.09054623 | 0.143058435 |
PHB | −0.17979782 | 0.017985676 | PRC1 | −0.03823675 | 0.469573522 |
POLR2A | −0.16735144 | 0.036239233 | RBCK1 | 0.002557887 | 0.478498029 |
POLR2F | −0.18849316 | 0.017322046 | RELA | −0.12211608 | 0.057838148 |
POLR2J | −0.18380023 | 0.005798006 | RIPK1 | −0.0370495 | 0.368548703 |
POLR2L | −0.21763683 | 0.01732348 | RPP14 | −0.02148104 | 0.226554319 |
PPP2R1A | −0.19027009 | 0.003022816 | SIL1 | −0.09891158 | 0.161295174 |
PRMT1 | −0.20861375 | 0.003149464 | STRAP | −0.11208718 | 0.105544333 |
QARS | −0.19534141 | 0.000879503 | SUPT16H | −0.1103425 | 0.1585083 |
RNF31 | −0.12674219 | 0.048562248 | TAB1 | −0.10182075 | 0.077284946 |
RPL8 | −0.21557521 | 0.020928307 | UBA3 | 0.125112432 | 0.1585083 |
RPS2 | −0.22193232 | 0.009801511 | VMP1 | 0.079953225 | 0.304995581 |
SF3A2 | −0.27189946 | 0.001678396 | WDR1 | −0.02369511 | 0.392659421 |
SHARPIN | −0.21693714 | 0.003149464 | CAPZB | 0.170981197 | 0.005016426 |
SMARCA4 | −0.24420365 | 0.000504813 | CFLAR | 0.49050373 | 2.26E-07 |
SUPT5H | −0.11043007 | 0.040195832 | |||
TAF6 | −0.18760288 | 0.00306836 | |||
TFPT | −0.23112836 | 0.006997517 | |||
THRA | −0.31436908 | 0.000747174 | |||
TIMM22 | −0.18787382 | 0.000747174 | |||
TMEM161 | −0.31722681 | 1.74E-05 | |||
TONSL | −0.2265871 | 0.030279691 | |||
TOP3A | −0.14123831 | 0.029872015 | |||
TUFM | −0.14949456 | 0.007083264 | |||
USP5 | −0.22581678 | 0.000303673 | |||
VPS25 | −0.16491795 | 0.007165671 | |||
VPS28 | −0.20945587 | 0.002049957 |
Genes whose gRNAs were significantly depleted in the T cell-treated group were aligned with their related human homologs. Based on the cut-off of lymphocyte infiltration scores (L scores), patients with melanoma in the TCGA dataset into high L score (L score >3) and low L score (L score ≤3) groups. The expression levels of selected genes between the high L score group versus the low L score group were compared. The Log2FC (high vs low) and adjusted p value for each candidate were calculated. Dual regulators are defined as genes with adjusted p<0.05 and Log2FC<0. Cytotoxicity regulators are defined as genes with either adjusted p≥0.05 or Log2FC≥0. The regulators identified by both selection conditions were highlighted in yellow. The cytotoxicity regulators identified under single selection condition were not shown.